Biomarkers in Cancer Approvals: New Opportunities and Challenges
Waterhouse Room, Gordon Hall, HMSThe FDA recently approved Keytruda and Vitrakvi, two cancer drugs targeting biomarkers without reference to the site of the disease. […]
The FDA recently approved Keytruda and Vitrakvi, two cancer drugs targeting biomarkers without reference to the site of the disease. […]
Join us for a panel discussion moderated by Jen Rice, Director of Business Development at Harvard Office of Technology Development […]
Please join the HLS Mississippi Delta Project for our annual Delta Celebration. We’ll be joined by Dr. Kecia Johnson, Assistant Professor at Mississippi State […]
Danielle S. Allen, James Bryant Conant University Professor at Harvard University, and Director of Harvard's Edmond J. Safra Center for Ethics, […]
Join Harvard Health Law Society for a panel with 2Ls who worked in health law last summer. Our panelists include […]
"Drivers of Health" will feature two panels of experts, the first of which will focus on the health-related needs of […]